Nuclear Imaging for Localization and Surgical Outcome Prediction in Epilepsy: A Review of Latest Discoveries and Future Perspectives

Overview

Journal Front Neurol

Specialty Neurology

Date 2023 Jan 2

PMID 36588897

Authors

Chanan Sukprakun

Supatporn Tepmongkol

Affiliations

Soon will be listed here.

Abstract

Background: Epilepsy is one of the most common neurological disorders. Approximately, one-third of patients with epilepsy have seizures refractory to antiepileptic drugs and further require surgical removal of the epileptogenic region. In the last decade, there have been many recent developments in radiopharmaceuticals, novel image analysis techniques, and new software for an epileptogenic zone (EZ) localization.

Objectives: Recently, we provided the latest discoveries, current challenges, and future perspectives in the field of positron emission tomography (PET) and single-photon emission computed tomography (SPECT) in epilepsy.

Methods: We searched for relevant articles published in MEDLINE and CENTRAL from July 2012 to July 2022. A systematic literature review based on the Preferred Reporting Items for Systematic Reviews and Meta-Analysis was conducted using the keywords "Epilepsy" and "PET or SPECT." We included both prospective and retrospective studies. Studies with preclinical subjects or not focusing on EZ localization or surgical outcome prediction using recently developed PET radiopharmaceuticals, novel image analysis techniques, and new software were excluded from the review. The remaining 162 articles were reviewed.

Results: We first present recent findings and developments in PET radiopharmaceuticals. Second, we present novel image analysis techniques and new software in the last decade for EZ localization. Finally, we summarize the overall findings and discuss future perspectives in the field of PET and SPECT in epilepsy.

Conclusion: Combining new radiopharmaceutical development, new indications, new techniques, and software improves EZ localization and provides a better understanding of epilepsy. These have proven not to only predict prognosis but also to improve the outcome of epilepsy surgery.

Citing Articles

Hypometabolic patterns of focal cortical dysplasia in PET-MRI co-registration imaging: a retrospective evaluation in a series of 83 patients.

Wang X, Hu W, Shao X, Zheng Z, Ai L, Sang L Front Neurosci. 2023; 17:1173534.

PMID: 37817803 PMC: 10561385. DOI: 10.3389/fnins.2023.1173534.

References

Jain A, Struck A, Woo K, Jaskowiak C, Hall L . Thalamic and basal ganglia metabolism on interictal F-FDG PET in temporal lobe epilepsy: an SUV-based analysis. Am J Nucl Med Mol Imaging. 2018; 8(1):41-49. PMC: 5840322. View

Takahashi M, Soma T, Kawai K, Koyama K, Ohtomo K, Momose T . Voxel-based comparison of preoperative FDG-PET between mesial temporal lobe epilepsy patients with and without postoperative seizure-free outcomes. Ann Nucl Med. 2012; 26(9):698-706. DOI: 10.1007/s12149-012-0629-9. View

Oldan J, Shin H, Khandani A, Zamora C, Benefield T, Jewells V . Subsequent experience in hybrid PET-MRI for evaluation of refractory focal onset epilepsy. Seizure. 2018; 61:128-134. DOI: 10.1016/j.seizure.2018.07.022. View

Tang Y, Liao G, Li J, Long T, Li Y, Feng L . FDG-PET Profiles of Extratemporal Metabolism as a Predictor of Surgical Failure in Temporal Lobe Epilepsy. Front Med (Lausanne). 2021; 7:605002. PMC: 7793721. DOI: 10.3389/fmed.2020.605002. View

Pustina D, Avants B, Sperling M, Gorniak R, He X, Doucet G . Predicting the laterality of temporal lobe epilepsy from PET, MRI, and DTI: A multimodal study. Neuroimage Clin. 2015; 9:20-31. PMC: 4536304. DOI: 10.1016/j.nicl.2015.07.010. View

Nugent A, Martinez A, dAlfonso A, Zarate C, Theodore W . The relationship between glucose metabolism, resting-state fMRI BOLD signal, and GABAA-binding potential: a preliminary study in healthy subjects and those with temporal lobe epilepsy. J Cereb Blood Flow Metab. 2015; 35(4):583-91. PMC: 4420874. DOI: 10.1038/jcbfm.2014.228. View

Fujitani S, Matsuda K, Nakamura F, Baba K, Usui N, Tottori T . Statistical parametric mapping of interictal 123I-iomazenil SPECT in temporal lobe epilepsy surgery. Epilepsy Res. 2013; 106(1-2):173-80. DOI: 10.1016/j.eplepsyres.2013.03.008. View

Newey C, Wong C, Wang Z, Chen X, Wu G, Alexopoulos A . Optimizing SPECT SISCOM analysis to localize seizure-onset zone by using varying z scores. Epilepsia. 2013; 54(5):793-800. DOI: 10.1111/epi.12139. View

Chen Y, Wei R, Yuan G, Gao D, Jin Q, Cui X . A new role of C-Choline PET in localizing the epileptogenic foci in insular cortex in the patients. CNS Neurosci Ther. 2019; 26(1):144-147. PMC: 6930826. DOI: 10.1111/cns.13215. View

10.

Liu F, Ruan W, Deng X, Song Y, Song W, Hu F . Efficacy of delayed F-FDG hybrid PET/MRI for epileptic focus identification: a prospective cohort study. Eur J Nucl Med Mol Imaging. 2020; 48(1):293-301. DOI: 10.1007/s00259-020-04935-3. View

11.

Ramchuankiat S, Jarumaneeroj P, Limotai C, Tepmongkol S, Rakvongthai Y . Impact of injection time on migration of SPECT seizure onset in temporal lobe epilepsy. Annu Int Conf IEEE Eng Med Biol Soc. 2017; 2017:1465-1468. DOI: 10.1109/EMBC.2017.8037111. View

12.

Hlauschek G, Sinclair B, Brinkmann B, Fuge J, Kwan P, OBrien T . The effect of injection time on rates of epileptogenic zone localization using SISCOM and STATISCOM. Epilepsy Behav. 2021; 118:107945. DOI: 10.1016/j.yebeh.2021.107945. View

13.

Traub-Weidinger T, Muzik O, Sundar L, Aull-Watschinger S, Beyer T, Hacker M . Utility of Absolute Quantification in Non-lesional Extratemporal Lobe Epilepsy Using FDG PET/MR Imaging. Front Neurol. 2020; 11:54. PMC: 7005011. DOI: 10.3389/fneur.2020.00054. View

14.

Yankam Njiwa J, Gray K, Costes N, Mauguiere F, Ryvlin P, Hammers A . Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis. Neuroimage Clin. 2015; 7:122-31. PMC: 4299974. DOI: 10.1016/j.nicl.2014.11.013. View

15.

Sequeira K, Tabesh A, Sainju R, DeSantis S, Naselaris T, Joseph J . Perfusion network shift during seizures in medial temporal lobe epilepsy. PLoS One. 2013; 8(1):e53204. PMC: 3544909. DOI: 10.1371/journal.pone.0053204. View

16.

Seshadri V, Zarroli K, Schetlick R, Massey J, Reyes J, Eluvathingal Muttikal T . Dynamic FDG-PET in localization of focal epilepsy: A pilot study. Epilepsy Behav. 2021; 122:108204. PMC: 8436183. DOI: 10.1016/j.yebeh.2021.108204. View

17.

Yankam Njiwa J, Bouvard S, Catenoix H, Mauguiere F, Ryvlin P, Hammers A . Periventricular [(11)C]flumazenil binding for predicting postoperative outcome in individual patients with temporal lobe epilepsy and hippocampal sclerosis. Neuroimage Clin. 2013; 3:242-8. PMC: 3814949. DOI: 10.1016/j.nicl.2013.07.008. View

18.

Ren S, Huang Q, Bao W, Jiang D, Xiao J, Li J . Metabolic Brain Network and Surgical Outcome in Temporal Lobe Epilepsy: A Graph Theoretical Study Based on F-fluorodeoxyglucose PET. Neuroscience. 2021; 478:39-48. DOI: 10.1016/j.neuroscience.2021.10.012. View

19.

Shin J, Chu K, Shin S, Jung K, Lee S, Lee Y . Clinical Applications of Simultaneous PET/MR Imaging Using (R)-[11C]-Verapamil with Cyclosporin A: Preliminary Results on a Surrogate Marker of Drug-Resistant Epilepsy. AJNR Am J Neuroradiol. 2015; 37(4):600-6. PMC: 7960172. DOI: 10.3174/ajnr.A4566. View

20.

Fu P, Zhang F, Gao J, Jing J, Pan L, Li D . NeuroGam Software Analysis in Epilepsy Diagnosis Using 99mTc-ECD Brain Perfusion SPECT Imaging. Med Sci Monit. 2015; 21:2801-8. PMC: 4581683. DOI: 10.12659/MSM.894566. View